These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1556789)

  • 1. Long-term mortality after primary prevention for cardiovascular disease.
    Mogadam M
    JAMA; 1992 Apr 22-29; 267(16):2184-5; author reply 2185-6. PubMed ID: 1556789
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term mortality after primary prevention for cardiovascular disease.
    Newman TB; Browner WS; Hulley SB
    JAMA; 1992 Apr 22-29; 267(16):2183-4; author reply 2185-6. PubMed ID: 1365813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular mortality in Spain].
    Villar Alvarez F; Banegas Banegas JR
    Rev Sanid Hig Publica (Madr); 1991; 65(1):5-7. PubMed ID: 1801163
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based use of statins for primary prevention of cardiovascular disease.
    Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
    Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Karl Popper and the cholesterol hypothesis].
    Ravnskov U
    Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2517. PubMed ID: 15477904
    [No Abstract]   [Full Text] [Related]  

  • 6. National cardiovascular prevention should be based on absolute disease risks, not levels of risk factors.
    Powles J; Shroufi A; Mathers C; Zatonski W; La Vecchia C; Ezzati M
    Eur J Public Health; 2010 Feb; 20(1):103-6. PubMed ID: 19505972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of cholesterol for cardiovascular disease mortality].
    Klemsdal TO
    Tidsskr Nor Laegeforen; 2005 Feb; 125(4):464. PubMed ID: 15742026
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender-specific aspects of cardiovascular disease.
    Roberts BH
    Med Health R I; 2005 Oct; 88(10):339-41. PubMed ID: 16350933
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.
    Strandberg TE; Salomaa VV; Naukkarinen VA; Vanhanen HT; Sarna SJ; Miettinen TA
    JAMA; 1991 Sep; 266(9):1225-9. PubMed ID: 1870247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mortality after primary prevention for cardiovascular disease.
    Modest G
    JAMA; 1992 Apr 22-29; 267(16):2184; author reply 2185-6. PubMed ID: 1556788
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases.
    Puska P; Vartiainen E; Tuomilehto J; Salomaa V; Nissinen A
    Bull World Health Organ; 1998; 76(4):419-25. PubMed ID: 9803593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease.
    Malcolm L
    N Z Med J; 1990 Aug; 103(896):402-4. PubMed ID: 2117264
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
    Brugts JJ; Deckers JW
    Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
    [No Abstract]   [Full Text] [Related]  

  • 15. [New European guidelines for the management of dyslipidaemia in cardiovascular prevention].
    Descamps OS; De Backer G; Annemans L; Muls E; Scheen AJ; ;
    Rev Med Liege; 2012 Mar; 67(3):118-27. PubMed ID: 22611827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol lowering with statins: how WOSCOPS confounded the skeptics.
    Shepherd J
    Atheroscler Suppl; 2007 Aug; 8(2):9-12. PubMed ID: 17586101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy over time of a short overall atherosclerosis management programme on the reduction of cardiovascular risk in patients after an acute coronary syndrome.
    Lafitte M; Pradeau V; Leroux L; Richeboeuf V; Tastet S; Boulon C; Paviot B; Bonnet J; Couffinhal T
    Arch Cardiovasc Dis; 2009 Jan; 102(1):51-8. PubMed ID: 19233109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease.
    N Engl J Med; 1991 Jan; 324(1):60-1. PubMed ID: 1984170
    [No Abstract]   [Full Text] [Related]  

  • 19. The latest report from Finland. A lesson in expectations.
    Paul O; Hennekens CH
    JAMA; 1991 Sep; 266(9):1267-8. PubMed ID: 1870255
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risk factors in Italy.
    Menotti A
    Prev Med; 1999 Dec; 29(6 Pt 2):S111-8. PubMed ID: 10641828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.